Xeltis Pulmonary Valved Conduit Safety and Performance Study

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2020

Primary Completion Date

October 31, 2021

Study Completion Date

October 31, 2026

Conditions
Heart Defects, Congenital
Interventions
DEVICE

Xeltis Pulmonary Valved Conduit

RVOT reconstruction

Trial Locations (4)

H-1096

Gottsegen György Hungarian Institute of Cardiology, Paediatric Cardiac Centre, Budapest

Unknown

Institute Jantung Negara, National Heart Institute, Kuala Lumpur

Childrens Heart Centre Slovak Republic, Bratislava

30-663

University Children's Hospital of Cracow (UCH),, Krakow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Xeltis

INDUSTRY